Goldentree Asset Management’s Ardent Health ARDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.5M Sell
1,580,423
-722,690
-31% -$6.85M 0.9% 26
2026
Q1
$19.7M Hold
2,303,113
1.17% 22
2025
Q4
$20.3M Buy
2,303,113
+1,150,000
+100% +$13.3M 1.1% 22
2025
Q3
$15.2M Hold
1,153,113
1.26% 16
2025
Q2
$15.7M Sell
1,153,113
-195,498
-14% -$2.63M 1.52% 17
2025
Q1
$18.5M Hold
1,348,611
1.32% 24
2024
Q4
$23M Buy
1,348,611
+100,000
+8% +$1.73M 1.77% 20
2024
Q3
$22.9M Buy
+1,248,611
New +$22.1M 1.83% 20

Other funds holding ARDT

Goldentree Asset Management's ARDT Position: Q2 2026 in Review

Goldentree Asset Management reduced its Ardent Health (ARDT) stake by 31% in Q2 2026, selling an estimated $6.85M and leaving 1,580,423 shares worth $15.5M. The position accounts for 0.9% of the portfolio, ranked #26.

Goldentree Asset Management first reported a position in ARDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $23M in Q4 2024. 139 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • Goldentree Asset Management held 1,580,423 shares of Ardent Health worth $15.5M as of Q2 2026.
  • Goldentree Asset Management sold 722,690 Ardent Health shares in Q2 2026, an estimated $6.85M.
  • Ardent Health made up 0.9% of Goldentree Asset Management's portfolio in Q2 2026, its #26 holding.
  • Goldentree Asset Management first reported a position in Ardent Health in Q3 2024 and has held it in 8 quarters since.
  • Goldentree Asset Management's Ardent Health position peaked at $23M in Q4 2024.
  • 139 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on Goldentree Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.